首页> 外文期刊>European journal of gastroenterology and hepatology >Time trends in incidence and prognosis of primary liver cancer and liver metastases of unknown origin in a Danish region, 1985-2004.
【24h】

Time trends in incidence and prognosis of primary liver cancer and liver metastases of unknown origin in a Danish region, 1985-2004.

机译:1985-2004年在丹麦地区,原发性肝癌和未知来源的肝转移的发生率和预后的时间趋势。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: Changes, over the last 20 years, in the diagnostic procedures and treatment of primary liver cancer (PLC) and liver metastases of unknown origin (LMUO) may have affected the clinical course of both cancers. Few longitudinal studies examined this issue. In a population-based setting, we studied changes in the incidence and prognosis of PLC and LMUO over time. METHODS: Between 1985 and 2004, we identified 2675 patients with PLC and LMUO in three Danish counties, with a population of 1.4 million. We computed the standardized incidence rate (SIR), ratio of PLC to LMUO diagnoses, median survival, and estimated mortality rate ratio adjusted for age, sex, and comorbidity. RESULTS: The SIR of PLC increased from 3.2 in 1985 to 5.0 in 2003, and the SIR of LMUO increased from 3.7 to 6.4. No increase was noted in the PLC-to-LMUO ratio over time (P=0.1 for trend). From 1985 to 2004, the median survival of PLC patients increased from 1.6 to 2.9 months whereas that of LMUO patients decreased from 1.7 to 1.3 months. Adjusting for age, sex, and comorbidity did not affect the mortality rate ratio estimates. CONCLUSIONS: The incidence of both PLC and LMUO increased over time, whereas the PLC-to-LMUO ratio remained unchanged. Median survival of PLC patients has increased whereas that of LMUO patients remained practically unchanged.
机译:目的:在过去的20年中,原发性肝癌(PLC)和未知来源的肝转移瘤(LMUO)的诊断程序和治疗方面的变化可能影响了这两种癌症的临床进程。很少有纵向研究探讨了这个问题。在基于人群的环境中,我们研究了PLC和LMUO的发生率和预后随时间的变化。方法:在1985年至2004年之间,我们在丹麦的三个县确定了2675例PLC和LMUO患者,人口为140万。我们计算了标准化发病率(SIR),PLC与LMUO诊断的比率,中位生存率以及根据年龄,性别和合并症调整的估计死亡率。结果:PLC的SIR从1985年的3.2增加到2003年的5.0,LMUO的SIR从3.7增加到6.4。随着时间的推移,PLC与LMUO的比例没有增加(趋势P = 0.1)。从1985年到2004年,PLC患者的中位生存期从1.6个月增加到2.9个月,而LMUO患者的中位生存期从1.7个月减少到1.3个月。调整年龄,性别和合并症不会影响死亡率比率的估计。结论:PLC和LMUO的发生率均随时间增加,而PLC与LMUO之比保持不变。 PLC患者的中位生存期已增加,而LMUO患者的中位生存期几乎保持不变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号